Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females
- PMID: 34049062
- PMCID: PMC8820163
- DOI: 10.1016/j.neurobiolaging.2021.04.003
Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females
Abstract
We assessed sex differences in amyloid- and tau-PET retention in 119 amyloid positive patients with mild cognitive impairment or Alzheimer's disease (AD) dementia. Patients underwent 3T-MRI, 11C-PIB amyloid-PET and 18F-Flortaucipir tau-PET. Linear ordinary least squares regression models tested sex differences in Flortaucipir-PET SUVR in a summary temporal region of interest as well as global PIB-PET. No sex differences were observed in demographics, Clinical Dementia Rating Sum of Boxes (CDR-SoB), Mini-Mental State Exam (MMSE), raw episodic memory scores, or cortical thickness. Females had higher global PIB SUVR (ηp²=.043, p=.025) and temporal Flortaucipir SUVR (ηp²=.070, p=.004), adjusting for age and CDR-SoB. Sex differences in temporal Flortaucipir-PET remained significant when controlling additionally for PIB SUVR and APOE4 status (ηp²=.055, p=.013), or when using partial volume-corrected data. No sex differences were present in areas of known Flortaucipir off-target binding. Overall, females demonstrated greater AD regional tau-PET burden than males despite clinical comparability. Further characterization of sex differences will provide insight into AD pathogenesis and support development of personalized therapeutic strategies.
Keywords: Alzheimer's disease; Amyloid; Apolipoprotein E; Positron emission tomography; Sex differences; Tau.
Copyright © 2021. Published by Elsevier Inc.
Figures
Similar articles
-
18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.J Alzheimers Dis. 2020;74(2):589-601. doi: 10.3233/JAD-191330. J Alzheimers Dis. 2020. PMID: 32065800 Clinical Trial.
-
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334. Brain. 2017. PMID: 28077397 Free PMC article.
-
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Brain. 2016 May;139(Pt 5):1551-67. doi: 10.1093/brain/aww027. Epub 2016 Mar 8. Brain. 2016. PMID: 26962052 Free PMC article.
-
What's the cut-point?: a systematic investigation of tau PET thresholding methods.Alzheimers Res Ther. 2022 Apr 5;14(1):49. doi: 10.1186/s13195-022-00986-w. Alzheimers Res Ther. 2022. PMID: 35382866 Free PMC article. Review.
-
Tau Imaging in Alzheimer's Disease Diagnosis and Clinical Trials.Neurotherapeutics. 2017 Jan;14(1):62-68. doi: 10.1007/s13311-016-0490-y. Neurotherapeutics. 2017. PMID: 27873182 Free PMC article. Review.
Cited by
-
A case for seeking sex-specific treatments in Alzheimer's disease.Front Aging Neurosci. 2024 Feb 13;16:1346621. doi: 10.3389/fnagi.2024.1346621. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38414633 Free PMC article. Review.
-
Associations between sex, body mass index and the individual microglial response in Alzheimer's disease.J Neuroinflammation. 2024 Jan 23;21(1):30. doi: 10.1186/s12974-024-03020-y. J Neuroinflammation. 2024. PMID: 38263017 Free PMC article.
-
A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles.Brain Commun. 2023 Nov 16;6(1):fcad305. doi: 10.1093/braincomms/fcad305. eCollection 2024. Brain Commun. 2023. PMID: 38187878 Free PMC article. Review.
-
Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.J Alzheimers Dis. 2024;97(1):31-74. doi: 10.3233/JAD-230527. J Alzheimers Dis. 2024. PMID: 38007653 Free PMC article. Review.
-
Temporal tau asymmetry spectrum influences divergent behavior and language patterns in Alzheimer`s disease.medRxiv [Preprint]. 2023 Nov 10:2023.11.10.23296836. doi: 10.1101/2023.11.10.23296836. medRxiv. 2023. PMID: 37986964 Free PMC article. Preprint.
References
-
- 2020. Alzheimer’s disease facts and figures, 2020. Alzheimers Dement. 16, 391–460. 10.1002/alz.12068 - DOI
-
- Alber J, Alladi S, Bae H-J, Barton DA, Beckett LA, Bell JM, Berman SE, Biessels GJ, Black SE, Bos I, Bowman GL, Brai E, Brickman AM, Callahan BL, Corriveau RA, Fossati S, Gottesman RF, Gustafson DR, Hachinski V, Hayden KM, Helman AM, Hughes TM, Isaacs JD, Jefferson AL, Johnson SC, Kapasi A, Kern S, Kwon JC, Kukolja J, Lee A, Lockhart SN, Murray A, Osborn KE, Power MC, Price BR, Rhodius-Meester HFM, Rondeau JA, Rosen AC, Rosene DL, Schneider JA, Scholtzova H, Shaaban CE, Silva NCBS, Snyder HM, Swardfager W, Troen AM, van Veluw SJ, Vemuri P, Wallin A, Wellington C, Wilcock DM, Xie SX, Hainsworth AH, 2019. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities. Alzheimers Dement. Transl. Res. Clin. Interv. 5, 107–117. 10.1016/j.trci.2019.02.001 - DOI - PMC - PubMed
-
- Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH, 2011. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 270–279. 10.1016/j.jalz.2011.03.008 - DOI - PMC - PubMed
-
- Armstrong NM, Huang C-W, Williams OA, Bilgel M, An Y, Doshi J, Erus G, Davatzikos C, Wong DF, Ferrucci L, Resnick SM, 2019. Sex differences in the association between amyloid and longitudinal brain volume change in cognitively normal older adults. NeuroImage Clin. 22, 101769. 10.1016/j.nicl.2019.101769 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
